BioSpace News Archive

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for clearance to begin a Phase 1/2a clinical trial of ARO-ENaC, the company’s investigational RNA interference (RNAi) therapeutic being developed as a treatment for patients with cystic fibrosis (CF), which is a rare disease caused by genetic mutations that lead to progressive deterioration in lung function due to poor cleara

CHI Institute’s mission for the last 30 years, has been to provide the tools and research to enhance your human experience.

Liepmann and Erickson add invaluable industry expertise to the Board with more than 60 combined years of nutrition and food science experience

Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company, today announced the appointment of Dr. Yun-Fu Hu as Chief Medical Officer

The U.S. Food and Drug Administration issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure.

aptihealth, the nation’s leading innovator in tech-enabled behavioral health engagement, today announced the expansion of its executive team with the appointment of Kori-Ann Taylor as Chief Marketing Officer.

Ceros, an experiential content creation platform, today announced Ceros Gives, a new initiative to support organizations in the fight against COVID-19.

Boston Scientific Corporation (NYSE: BSX) today announced that its Annual Meeting of Stockholders (the “Annual Meeting”) will be held exclusively in a virtual meeting format at the previously announced date and time of May 7, 2020 at 8:00 a.m. Eastern Time.

Today, JobsOhio and Battelle announced a partnership to provide vital N95 respirator masks to health care professionals at Ohio hospitals, nursing homes and other medical facilities during the COVID-19 pandemic.

Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic,